- Coronavirus
- OverviewOverview
Find out how we support our customers' efforts during the COVID-19 pandemic. From product recommendations to useful resources for healthcare professionals.
- Anti-profiteering statementAnti-profiteering statement
We do not condone inflating prices in the wake of the coronavirus outbreak. Read our full statement on product availability and our efforts to counteract inflated prices.
Coronavirus
Find out how we support our customers' efforts during the COVID-19 pandemic. From product recommendations to useful resources for healthcare professionals.
- Overview
- About us
- Who we areWho we are
GAMA Healthcare is a dynamic, innovative company at the forefront of infection prevention technology. We specialise in the manufacture of revolutionary IPC products.
- What we doWhat we do
We help keep people safe. Our cutting-edge research lets us offer a wide range of effective, pioneering IPC solutions as well as unparalleled training and support.
- ResponsibilityResponsibility
We're proud to act responsibly as an employer, as a manufacturer and as a part of the global IPC community, holding ourselves to high standards across all our operations.
About us
At GAMA we help prevent infections to save and improve lives. Find out what makes us one of the fastest-growing healthcare companies, leading the way in IPC.
- Who we are
- Products
- Our productsOur products
Our aim is to produce effective and clinically proven infection prevention products. Available across the globe, they help reduce the spread of infections and save lives.
- By brand
- ClinellClinell
Combining innovative technology with ease of use, Clinell products provide the most effective IPC solution.
- RediroomRediroom
Instant temporary isolation room to provide hospitals with flexibility and improve their isolation capacity.
- HEXIHEXI
High-quality sterile skin disinfection products with chlorhexidine, designed to be simple and effective.
- CarellCarell
Our gentle, dermatologically-tested products help healthcare professionals with every aspect of patient care.
- Clinell
- By sector
- For hospitalsFor hospitals
Our products are used in 9 out of 10 NHS hospitals. Designed by doctors to protect staff and patients.
- For homeFor home
NHS' number 1 disinfectant wipes, now available for personal use, to help protect your home and loved ones.
- For workplacesFor workplaces
Making workplaces safer, GAMA offers a professional range of products to secure your staff and business.
- For hospitals
- By category
Products
Our aim is to produce effective and clinically proven infection prevention products. Available across the globe, they help reduce the spread of infections and save lives.
- Our products
- Training
Training
GAMA’s engaging, interactive training programme was developed in collaboration with leading infection prevention specialists, to fit your organisation's needs.
- Research
Research
At our cutting-edge facility, Fellows Research Centre in Halifax, our R&D team is comitted to creating novel infection prevention solutions and protecting patients.
- Latest
Latest
Find out about the latest developments in the GAMA world, summaries of the recent research papers and read about our team, our events and the latest product launches.
- Contact us
Contact us
Find contact details of our friendly sales teams and see where our offices are across the globe. Or for general enquiries fill out the form to get in touch with us.
Environmental contamination risk from asymptomatic SARS-CoV-2 infection
29th June 2020
Research
There is emerging evidence that contaminated surfaces play a role in the transmission of the SARS-CoV-2 virus that causes COVID-19.
This is in line with the diverse transmission routes of other respiratory viruses such as SARS-CoV-1 and influenza. One of the key features of SARS-CoV-2 is the documented spread from people with asymptomatic and pre-symptomatic infection. A new study has identified contamination with SARS-CoV-2 surrounding patients with asymptomatic infection.
Environmental sampling was performed around 13 patients with laboratory confirmed SARS-CoV-2 infection. 11 patients had mild symptoms, two patients had no symptoms at all. A total of 44 of 112 (39.3%) surface samples were positive for SARS-CoV-2 by RT-PCR, and air samples were negative. Importantly, four surfaces in the room of a patient without symptoms were found to be contaminated with SARS-CoV-2 RNA. The research team did not attempt to culture SARS-CoV-2 from the surfaces, so it is not clear whether the RNA is from viable virus.
This small but important study illustrates the risk of surface contamination from patients with mild and asymptomatic SARS-CoV-2 infection. It also seems likely that staff with asymptomatic infection will also be contaminating their environment, which creates the risk of contact transmission to patients and other staff. These findings reinforce the need for enhanced cleaning and disinfection during the of the COVID-19 pandemic.
Share this article
Tags
Latest News
More Than Skin Deep: Improving patient hand hygien…
A study on improving patient hand hygiene in a District General H…
Contamination of healthcare products by Burkholder…
The ubiquitous nature of microorganisms requires manufacturers to…
World Continence Week: Incontinence Myths vs. Fact…
In honour of World Continence Week, we thought we’d set the recor…
Staying safe on your staycation
We discuss everything from where you can visit to what to pack, t…